PM.5.9. Asocierea toxinei botulinice tip A cu tratamentul antimuscarinic

Botulinum toxin is already well established as a second line therapy for the overactive detrusor, despite several drawbacks, which include an increased cost and the potential for more severe complications compared to antimuscarinics. Even when combined with botulinum toxin, antimuscarinics did not c...

Full description

Saved in:
Bibliographic Details
Published inRomanian journal of urology Vol. 18; no. 2; p. 56
Main Authors Persu, C, Chirca, N, Dida, T, Buzescu, B, Jinga, V
Format Journal Article
LanguageEnglish
Romanian
Published Bucharest Romanian Journal of Urology 01.04.2019
Subjects
Botulinum toxin
Romania
Online AccessGet full text

Cover

More Information
Summary:Botulinum toxin is already well established as a second line therapy for the overactive detrusor, despite several drawbacks, which include an increased cost and the potential for more severe complications compared to antimuscarinics. Even when combined with botulinum toxin, antimuscarinics did not cause acute urinary retention. The increased cost of treatment might be balanced by the longer period of efficacy.
ISSN:1842-2187